Device Authority is a global leader in Identity and Access Management (IAM) for the Internet of Things (IoT) and Blockchain. Its KeyScaler platform provides trust for IoT devices and the IoT ecosystem, to address the challenges of securing the Internet of Things. KeyScaler uses breakthrough technology including Dynamic Key Generation (DDKG) and PKI Signature_ that delivers unrivaled simplicity and trust to IoT devices. This solution delivers automated device provisioning, authentication, credential management, and policy-based end-to-end data security/encryption.
Konektio connects the digital and physical worlds to digitally transform global industrial and manufacturing customers. Their IIoT SaaS product AssetMinder®, gives organizations visibility and control of their assets across the factory and externally in the field. AssetMinder® captures usage and performance data from smart digital sensors, providing advanced insights to unlock data-driven intelligence that optimizes processes, condition monitoring, uptime, and profitability across a range of industries including manufacturing, transportation, utilities, smart infrastructure, and food processing.
Wyld Networks develops and sells innovative wireless technology solutions that enables affordable connectivity anywhere in the World, addressing the problems for businesses and people regarding the lack of global mobile network coverage. The solutions are mainly targeted to wireless connectivity for the Internet of Things (IoT) and people.
Wyld Networks Ltd was formed in Cambridge, UK in 2016 and is a wholly owned subsidiary of Wyld Networks AB.
The Wyld Networks share (WYLD) is traded on the Nasdaq First North Growth Market.
Talking Medicines is a data tech company capturing, curating and structuring the global voice of the patient on launched medicines. The company uses a collection of tools including AI, ML and NLP technologies to capture and analyse the conversations and behaviours of patients at home. Through mapping the patient voice to regulated medicine information, the company is able to build data points to deliver intelligence on usage across medicines driven by patient data. This intelligence meets compliance for the sector and enables marketing in big pharma to measure patient confidence in their medicines & action the levers for share growth.
Please fill in your details to subscribe to our mailing list to receive press releases from Tern PLC and the companies it works with. Please note that by clicking submit, you are providing consent for IFC Advisory and Tern PLC to store your contact details for this purpose.